BRPI0821105A2 - ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular - Google Patents

ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Info

Publication number
BRPI0821105A2
BRPI0821105A2 BRPI0821105A BRPI0821105A BRPI0821105A2 BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2 BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A BRPI0821105 A BR PI0821105A BR PI0821105 A2 BRPI0821105 A2 BR PI0821105A2
Authority
BR
Brazil
Prior art keywords
diseases
therapeutic
diagnostic tools
vascular function
alter vascular
Prior art date
Application number
BRPI0821105A
Other languages
English (en)
Inventor
Erik Sjoerd Gerard Stroes
Hans Vink
Original Assignee
Academisch Ziekenhuis Maastricht
Univ Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39247715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0821105(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Academisch Ziekenhuis Maastricht, Univ Maastricht filed Critical Academisch Ziekenhuis Maastricht
Publication of BRPI0821105A2 publication Critical patent/BRPI0821105A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/328—Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821105A 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular BRPI0821105A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122043 2007-11-30
PCT/EP2008/066524 WO2009068685A1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function

Publications (1)

Publication Number Publication Date
BRPI0821105A2 true BRPI0821105A2 (pt) 2015-10-06

Family

ID=39247715

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821105A BRPI0821105A2 (pt) 2007-11-30 2008-12-01 ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular

Country Status (12)

Country Link
US (1) US8759095B2 (pt)
EP (1) EP2215480B1 (pt)
JP (1) JP5597543B2 (pt)
CN (1) CN101918845B (pt)
AT (1) ATE554396T1 (pt)
BR (1) BRPI0821105A2 (pt)
CA (1) CA2706307C (pt)
DK (1) DK2215480T3 (pt)
ES (1) ES2386231T3 (pt)
PL (1) PL2215480T3 (pt)
PT (1) PT2215480E (pt)
WO (1) WO2009068685A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918845B (zh) 2007-11-30 2014-01-29 马斯特里赫特大学 评估糖萼状态的方法及其在鉴定血管相关疾病中的应用
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US10070796B2 (en) 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
US9943572B2 (en) 2015-04-08 2018-04-17 Microvascular Health Solutions, LLC Synergistic glycocalyx treatment compositions and methods
US10449209B2 (en) 2015-04-29 2019-10-22 Arterez, Llc Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
US10507252B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
US10507253B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
WO2018208846A1 (en) * 2017-05-08 2018-11-15 Microvascular Health Solutions, LLC Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same
CN107271348B (zh) * 2017-07-06 2019-11-15 苏州大学 一种医用人造管道渗透性能测试系统及其使用方法
CA3087305A1 (en) * 2017-12-13 2019-06-20 Glx Analytix Aps Biomarkers for multiple sclerosis
CN108681510A (zh) * 2018-05-21 2018-10-19 迈克医疗电子有限公司 数据处理方法及装置
EP3623816A1 (en) 2018-09-12 2020-03-18 GLX Analytix ApS Glx-derived molecule detection
DK3666883T3 (da) * 2018-12-12 2025-03-31 Zhongke Xinray Suzhou Biological Tech Co Limited Fremgangsmåde til screening af forbindelser, der har forebyggende og terapeutiske aktiviteter mod endotelglycocalyx-relaterede sygdomme
US11852577B2 (en) * 2021-09-29 2023-12-26 Orange Biomed Ltd., Co. Apparatus for measuring properties of particles in a solution and related methods
JP2025540023A (ja) 2022-12-09 2025-12-11 オレンジ バイオメッド カンパニー リミテッド 赤血球の特性を測定するためのサンプル検査システム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP3566756B2 (ja) * 1993-09-03 2004-09-15 謙 石原 非侵襲血液分析装置とその方法
CA2385849A1 (en) * 1999-09-23 2001-03-29 Richard G. Nadeau Medical applications of orthogonal polarization spectral imaging
EP1501565B1 (de) * 2002-05-09 2006-11-02 Hemoteq GmbH Verbindungen und verfahren zur hemokompatiblen beschichtung von oberflächen
EP1661516B1 (en) 2003-09-02 2012-08-15 Koji Sode Glucose sensor and glucose level measuring apparatus
JP2007536974A (ja) 2004-05-14 2007-12-20 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 光ファイバプローブ
JP2007054483A (ja) 2005-08-26 2007-03-08 Olympus Corp 装着型顕微鏡システム
WO2007075388A2 (en) * 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
CN101918845B (zh) 2007-11-30 2014-01-29 马斯特里赫特大学 评估糖萼状态的方法及其在鉴定血管相关疾病中的应用

Also Published As

Publication number Publication date
EP2215480B1 (en) 2012-04-18
WO2009068685A1 (en) 2009-06-04
PL2215480T3 (pl) 2012-09-28
CN101918845A (zh) 2010-12-15
US20100304424A1 (en) 2010-12-02
DK2215480T3 (da) 2012-07-30
ATE554396T1 (de) 2012-05-15
CN101918845B (zh) 2014-01-29
CA2706307A1 (en) 2009-06-04
US8759095B2 (en) 2014-06-24
CA2706307C (en) 2017-01-17
PT2215480E (pt) 2012-07-18
JP5597543B2 (ja) 2014-10-01
ES2386231T3 (es) 2012-08-14
JP2011507560A (ja) 2011-03-10
EP2215480A1 (en) 2010-08-11

Similar Documents

Publication Publication Date Title
BRPI0821105A2 (pt) ferramentas terapêuticas e de diagnóstico para doenças que alteram a função vascular
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
ECSP11011417A (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
PA8774501A1 (es) Nueva sales y sus usos
MX2013001362A (es) Inmunoglubinas de dominio variable doble y usos de las mismas.
MA32934B1 (fr) Combinaisons inhibitrices hsp90
ECSP10010580A (es) Inmunoglobulinas duales de dominio variable y sus aplicaciones
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
GT201200109A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
GT200800123A (es) Compuestos mimeticos de lisina modificados
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
BRPI1008692A2 (pt) moléculas de anticorpos tendo especificidade para ox40 humano.
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
EP2153354A4 (en) FREE ENHANCED SEARCH PROCESSING VIA TEXT MESSAGE TRANSMISSION
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
CY1116802T1 (el) Ετεροκυκλικες ενωσεις
BR112014008224A2 (pt) derivados do fator vii e viia de coagulação sanguínea, conjugados e complexos que incluem o mesmo e utilização do mesmo
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
BRPI0814346A2 (pt) Uso de imidazoquinolinas para o tratamento de doenças dependentes de egfr ou doenças que adquiriram resistência a agentes que são direcionados aos membros da família de egfr.
ATE476655T1 (de) Doxorubicin-immuntest
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
ATE517642T1 (de) Kombination zum verkleben von biologischen geweben
FR2910330B1 (fr) Indicateur de sterilisation.
BRPI0909288A2 (pt) Inibidores da mmp-2 e/ou da mmp-9

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL